戻る
「早戻しボタン」を押すと検索画面に戻ります。 [閉じる]

コーパス検索結果 (1語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 because most disease-associated variants are non-coding and functional characterization of these sign
2              However, ~ 98% of the genome is non-coding and includes regulatory elements whose normal
3 11265259 and rs181704186), both of which are non-coding and more common in individuals of African anc
4 istant nucleotide variants covary, including non-coding and ORF1ab sites covarying with the D614G spi
5                   These variants were mainly non-coding and reached at least nominal significance in
6 association studies (GWAS) are predominantly non-coding and typically attributed to altered regulator
7         Overall, this work demonstrates that non-coding AR binding sites are frequently mutated in pr
8 acterial transcriptomic data commonly ignore non-coding but functional elements e.g. small RNAs, long
9        Disruption of this stem abolishes the non-coding, but not the coding, function of the endogeno
10                                     However, non-coding cancer driver mutations are less well-charact
11       These include sex-biases in coding and non-coding cancer drivers, mutation prevalence and strik
12 data reveal how expression variation through non-coding cis variation at FLC has enabled Arabidopsis
13                               We find that a non-coding constraint mutation in the SEMA3C promoter re
14                       Performing analysis on non-coding constraint mutations and their position relat
15                   These results suggest that non-coding constraint mutations could play an essential
16 y genes, we find a significant enrichment of non-coding constraint mutations in the neighborhood of 7
17  also identify 1776 other genes enriched for non-coding constraint mutations with likely regulatory p
18 e than 98% of the human genome is made up of non-coding DNA, but techniques to ascertain its contribu
19  can support more and larger genes, far more non-coding DNA, greater regulatory complexity, and thous
20  genomic regions or de novo, from previously non-coding DNA.
21  patterns of weak selection in predominantly non-coding DNA.
22 ciations with specific mutational processes, non-coding driver genes and evolutionary features.
23  mapped many protein-coding drivers, yet few non-coding drivers are known because genome-wide discove
24 enome contains arrays of extremely conserved non-coding elements termed genomic regulatory blocks (GR
25                      Enhancers are important non-coding elements, but they have traditionally been ha
26 ergo bidirectional transcription to generate non-coding enhancer RNAs (eRNAs).
27 tates downstream analysis of both coding and non-coding features.
28                                   Functional non-coding (fnc)RNAs are nucleotide sequences of varied
29 es isoform-resolved annotation of coding and non-coding functional domains, motifs, and sites, in com
30 iscovered recurrent SVs targeting coding and non-coding functional elements known to promote prostate
31 Efficient translational bypassing of a 50-nt non-coding gap in a phage T4 topoisomerase subunit gene
32 lls for targeted discovery and validation of non-coding gene variants affecting gene expression and d
33 iants that drive cancer are less frequent in non-coding genes and regulatory sequences than in protei
34                  In particular AD-associated non-coding-genes play an important, as yet largely unexp
35 sed INFERence of the molecular mechanisms of NOn-coding genetic variants (SparkINFERNO), a scalable b
36 entify novel therapeutic targets in the vast non-coding genome to enhance radiation therapy.
37 e vast majority of these variants lie in the non-coding genome, where they likely function through in
38 lable bioinformatics pipeline characterizing non-coding genome-wide association study (GWAS) associat
39 dscape of infrequent driver mutations in the non-coding genome.
40 iologically relevant SVs altering coding and non-coding genome.
41                                    While few non-coding genomic elements are recurrently mutated in t
42 can be used for genome editing of coding and non-coding genomic regions effectively.
43 matic mutation enrichment in both coding and non-coding genomic regions from WGS data.
44 impact of single nucleotide polymorphisms in non-coding genomic regions.
45 ole in GBM, underscoring the need to connect non-coding genomic variation to biological function and
46 omerase reverse transcriptase (TERT) and the non-coding human telomerase RNA (hTR), which serves as a
47                                              Non-coding IPS1 RNA is highly expressed during Pi starva
48 g), in addition to four uncharacterized long non-coding (lnc) RNA genes and part of a novel protein-c
49 n of VINR, a Drosophila VSR-interacting long non-coding (lnc) RNA that activates non-canonical innate
50 w material for the evolution of diverse long non-coding (lnc) RNAs by non-adaptive mechanisms, such a
51 sed with transcription units specifying long non-coding (lnc) RNAs, there are many opportunities for
52 ormation about under-studied genes including non-coding lncRNAs, (ii) replying to requests for inform
53 These results suggest that a large number of non-coding loci affect the development and progression o
54                We explore the representative non-coding loci and their linked genes of each cluster a
55 ced rate of small changes in gene structure, non-coding loci show even much larger changes.
56 classes and the detection of novel expressed non-coding loci.
57 ances VEGFA expression by the targeting of a non-coding microRNA that regulates its expression.
58  DNA methylation, histone modifications, and non-coding miRNAs.
59                   MicroRNAs (miRs) are small non-coding molecules that regulate post-transcriptional
60                   microRNAs (miRs) are small non-coding molecules that regulate post-transcriptional
61 ulti-faceted pathway and network analyses of non-coding mutations across 2583 whole cancer genomes fr
62  however the true extent of how such somatic non-coding mutations affect RNA splicing are largely une
63 cer genes and mechanisms that are altered by non-coding mutations and offer insights into additional
64 r types, we integrated genes with coding and non-coding mutations and revealed frequently mutated pat
65                                              Non-coding mutations at the far end of a large gene dese
66                                              Non-coding mutations can create splice sites, however th
67 annotating the splicing impact of coding and non-coding mutations in future large-scale analyses.
68       The functional consequences of somatic non-coding mutations in ovarian cancer (OC) are unknown.
69         RNA splicing is primarily altered by non-coding mutations in this cohort, and samples contain
70 tions in this cohort, and samples containing non-coding mutations in well-known RNA splicing factors
71 ations suggests that splice sites created by non-coding mutations interact with pre-existing potentia
72  this cohort, we identify 93 genes harboring non-coding mutations that cluster into several modules o
73 nd 9494 cases with WES data, discovering 562 non-coding mutations that lead to splicing alterations.
74 al patterns of somatic mutations, especially non-coding mutations, and their roles in defining molecu
75 haracterized and only a handful of recurrent non-coding mutations, most notably TERT promoter mutatio
76  facilitate the identification of functional non-coding mutations, we present dbInDel, a database whe
77 esses had variable proportions of coding and non-coding mutations, with chromatin remodeling and prol
78 ly whole-genome sequencing (WGS) to identify non-coding mutations, with regulatory potential in GBM,
79 e buffered against the effects of disruptive non-coding mutations.
80 ng Wnt and Notch, altered by both coding and non-coding mutations.
81 Using both coding (beta-actin mRNA) and long non-coding (NEAT1) RNAs, we show that the Mango array do
82              This is especially true for the non-coding part of the genome which is enormous yet poor
83 is that most associated variants fall in the non-coding part of the human genome.
84 low for both the identification of candidate non-coding pathogenic variants and their functional vali
85 xbp-1 mRNA bifurcates it into a coding and a non-coding pathway; modulation of the two pathways may a
86                             One way in which non-coding polymorphisms could cause disease is by affec
87 ease-associated risk loci are located in the non-coding region of the genome and therefore, their tar
88 r point mutations and structural variants in non-coding regions across 2,658 genomes from the Pan-Can
89 e proportion of risk variants are located in non-coding regions and remain unexplained by current exp
90 ied our MGW-prioritization approach to three non-coding regions associated with systemic lupus erythe
91 specific HLA peptides derived from annotated non-coding regions could elicit anti-tumor immune respon
92 ecent years have revealed essential roles of non-coding regions in gene regulation.
93        These results suggest that SVs within non-coding regions may play an important role in ADHD de
94  results uncover a function for ribosomes on non-coding regions of RNAs and reveal the mechanisms und
95 ore meaningful prediction in both coding and non-coding regions of the cancer genome.
96 ch 68.4% involved associations with flanking non-coding regions of the gene.
97 r understanding of the rules that govern the non-coding regions of the genome is less complete than o
98 ion factors, other protein coding genes, and non-coding regions of the genome with regulatory potenti
99    For somatic point mutations in coding and non-coding regions of the genome, we propose CScape-soma
100 nown aetiological variants in the coding and non-coding regions of the genome.
101  crucial role in the study of the effects of non-coding regions on the molecular classification of ca
102 graphical reports are offered for coding and non-coding regions that annotate the potential impact of
103 y and clinical covariates and detect loci in non-coding regions that are difficult to interpret.
104 ding those targeting intergenic and intronic non-coding regions that eluded previous exome focused st
105    Many disease-associated loci are found in non-coding regions that house regulatory elements.
106 eview a GRB-based approach to assign loci in non-coding regions to potential target genes, and apply
107 ut those somatic mutations that occur at the non-coding regions where AR binds DNA.
108                 The majority of these are in non-coding regions, and are commonly assigned to the nea
109 of the identified associated variants are in non-coding regions, and presumably influence gene expres
110     To further characterize the burdening of non-coding regions, we used NIMBus to screen transcripti
111 lanced accuracy in coding regions and 69% in non-coding regions, whereas even higher accuracy may be
112 ften unclear, especially when they appear in non-coding regions.
113 vel variants and/or may be uninformative for non-coding regions.
114 139 microsatellites, of which 71 were in the non-coding regions.
115 ng need to understand the functional role of non-coding regulatory elements (REs).
116 t the majority of loci are thought to affect non-coding regulatory elements, the second question is o
117 ease have been performed, alterations in the non-coding regulatory regions of GBM have largely remain
118 tion in the CNS, elucidating the function of non-coding regulatory sequences in neurobiology and link
119              These experiments validated new non-coding regulatory sequences near induced and/or esse
120                     Here, we investigate the non-coding regulatory space in the maize (Zea mays) geno
121  used as an indicator of the significance of non-coding regulatory variants.
122  and establishes a framework for identifying non-coding regulatory variation with phenotypic conseque
123                                              Non-coding repeat expansions in different genes have bee
124                 We further identified a long-non coding RNA transcribed at CHPT1 enhancer (also known
125 egulated by the interaction between the long non-coding RNA (lncRNA) DIGIT and the bromodomain and ex
126 nt of these are located within BANCR, a long non-coding RNA (lncRNA) exclusively expressed in primate
127                        Misregulation of long non-coding RNA (lncRNA) genes has been linked to a wide
128                                   While long non-coding RNA (lncRNA) genes have attracted a lot of at
129                        Herein, based on long non-coding RNA (lncRNA) profiling induced by active AKT,
130  RNA myeloid-specific 1 (HOTAIRM1) is a long non-coding RNA (lncRNA) that plays a pivotal role in reg
131 ide Metabolism Regulator (lincNMR) is a long non-coding RNA (lncRNA) which is induced in hepatocellul
132 d GC, by targeting and downregulating a long non-coding RNA (lncRNA), LOC553103.
133 ctivity of the promoter of LOXL1-AS1, a long non-coding RNA (lncRNA).
134 ng, we systematically annotated multi-exonic non-coding RNA (mencRNA) genes transcribed from 1.5-Mb i
135 xbp-1 mRNA cleavage is a biologically active non-coding RNA (ncRNA) essential for axon regeneration i
136             A new concept is emerging in the non-coding RNA (ncRNA) field: an increasing number of nc
137                                  Research on non-coding RNA (ncRNA) is a rapidly expanding field.
138 es are sites for RNA biology including small non-coding RNA (ncRNA) mediated gene silencing.
139 CREs could be identified by context-specific non-coding RNA (ncRNA) profiling, based on the observati
140 r genes, virus-host interactions involved in non-coding RNA (ncRNA), target gene and microRNA express
141 om the screen, progenitor renewal associated non-coding RNA (PRANCR), using RNA interference-mediated
142 Recent studies have demonstrated sperm small non-coding RNA (sncRNA) populations vary in response to
143               We identify the IFN-stimulated non-coding RNA 1 (INCR1) as a long noncoding RNA (lncRNA
144 ntibodies interact with beta-amyloid, a long non-coding RNA AC099552.4 (p = 1.2 x 10(-7)), and a zinc
145                                The extent of non-coding RNA alterations in patients with sepsis and t
146 C across hundreds of residues in rRNA, tRNA, non-coding RNA and mRNA from hyperthermophilic archaea.
147 analysis of leukocyte RNA we found that long non-coding RNA and, to a lesser extent, small non-coding
148                                       A long non-coding RNA called GRASLND is essential to help stem
149 ed UBE3A allele is silenced in cis by a long non-coding RNA called UBE3A-ATS.
150                                         Long non-coding RNA expression, but not small non-coding RNA,
151 xpressed genes NEXMIF, SLC16A2, and the long non-coding RNA gene FTX.
152 n of PPARalpha directly upregulates the long non-coding RNA gene Gm15441 through PPARalpha binding si
153  and global annotation of protein-coding and non-coding RNA genes in a manner orthogonal to gene expr
154 d across all cohorts was located in the long non-coding RNA growth arrest specific five gene (GAS5) (
155 presents a paradigm for the function of long non-coding RNA in epigenetic regulation, although how it
156 se H-mediated cleavage, splicing modulation, non-coding RNA inhibition, gene activation and programme
157            We hypothesized that U3 snoRNA, a non-coding RNA involved in ribosomal RNA maturation, is
158 sed modulation of a triple helix in the long non-coding RNA metastasis-associated lung adenocarcinoma
159 ional study of EV-mediated transfer of small non-coding RNA molecules at single-cell resolution.
160                                     The long non-coding RNA NEAT1 serves as a scaffold for the assemb
161                   Mature microRNAs are short non-coding RNA sequences which upon incorporation into t
162 dependent tool evaluates pre-processed small non-coding RNA sequencing (sncRNA-seq) data, i.e. expres
163                     A fast-growing number of non-coding RNA structures have been resolved and deposit
164 ato spindle tuber viroid (PSTVd), a circular non-coding RNA that replicates and spreads systemically
165 on-coding RNA and, to a lesser extent, small non-coding RNA were significantly altered in sepsis rela
166                                     The long non-coding RNA Xist establishes an intra-chromosomal com
167 h CIZ1, including interaction with XIST long-non-coding RNA, epigenetic maintenance and regulation of
168                       A single P. aeruginosa non-coding RNA, P11, is both necessary and sufficient to
169 ong non-coding RNA expression, but not small non-coding RNA, was largely recapitulated in human endot
170                              Long intergenic non-coding RNA-Nucleotide Metabolism Regulator (lincNMR)
171 he translational potential of XIST, a unique non-coding RNA.
172 ontains CpG-rich promoters for TERRA, a long non-coding RNA.
173                Our results suggest that this non-coding-RNA-dependent mechanism evolved to survey the
174 enes (2.94-fold), GWAS loci (1.52-fold), and non-coding RNAs (1.44-fold), compared with random distri
175 how that the mutation and regulation of long non-coding RNAs (lncRNAs) are associated with various hu
176                                         Long non-coding RNAs (lncRNAs) are components of epigenetic c
177 ein-coding genes, the majority of human long non-coding RNAs (lncRNAs) are considered non-conserved.
178                                         Long non-coding RNAs (lncRNAs) are defined as non-protein-cod
179                                         Long non-coding RNAs (lncRNAs) are emerging regulators of gen
180                                         Long non-coding RNAs (lncRNAs) are emerging regulators of pat
181                                         Long non-coding RNAs (lncRNAs) are important regulators of de
182                                         Long non-coding RNAs (lncRNAs) are of fundamental biological
183                                         Long non-coding RNAs (lncRNAs) are often aberrantly expressed
184 known ASD risk genes code for proteins, long non-coding RNAs (lncRNAs) as essential regulators of gen
185                                         Long non-coding RNAs (lncRNAs) constitute a significant fract
186                                         Long non-coding RNAs (lncRNAs) contribute to cardiac (patho)p
187                                         Long non-coding RNAs (lncRNAs) exhibit highly cell type-speci
188                                         Long non-coding RNAs (lncRNAs) have emerged as essential infl
189            Despite our understanding of long non-coding RNAs (lncRNAs) in primary colon cancer, their
190 o identify binding proteins of specific long non-coding RNAs (lncRNAs) in the native cellular context
191 the targeting and spreading patterns of long non-coding RNAs (lncRNAs) on chromatin requires a techni
192   As ncRNAs such as microRNAs (miRNAs), long non-coding RNAs (lncRNAs) or circular RNAs (circRNAs) ca
193                                         Long non-coding RNAs (lncRNAs) play an important role in gene
194                                         Long non-coding RNAs (lncRNAs) play crucial roles in regulati
195  of multi-protein DNA complexes, so how long non-coding RNAs (lncRNAs) regulate DNA repair is less we
196  is transcribed and that there are more long non-coding RNAs (lncRNAs) than protein coding genes, sev
197 alian genome is transcribed, generating long non-coding RNAs (lncRNAs) that can undergo post-transcri
198                                         Long non-coding RNAs (lncRNAs) with a length of > 200 nucleot
199                    Here, we report that long non-coding RNAs (lncRNAs), a recently discovered class o
200  expression of LRRK2 and two long intergenic non-coding RNAs (lncRNAs), LINC02555 and AC079630.4, in
201 oma (LUAD) based on multi-omics data of long non-coding RNAs (lncRNAs), microRNAs and mRNAs.
202 and predicting circular RNAs from other long non-coding RNAs (lncRNAs).
203 ts (TEs) comprise a large proportion of long non-coding RNAs (lncRNAs).
204 rates, while rRNA, tRNA, and other conserved non-coding RNAs (ncRNAs) are excluded from these bodies.
205                                        Small non-coding RNAs (ncRNAs) are short non-coding sequences
206            The functional importance of many non-coding RNAs (ncRNAs) generated by repetitive element
207                                              Non-coding RNAs (ncRNAs) have been reported to control f
208  (DMD) is a surveillance pathway for certain non-coding RNAs (ncRNAs) including ribosomal RNAs (rRNAs
209                                        Small non-coding RNAs (sncRNAs) play important roles in health
210  conserved between mouse and human XIST long non-coding RNAs and defined protein communities whose bi
211  gene transcripts, separating short and long non-coding RNAs and predicting circular RNAs from other
212 R, that automates the discovery of expressed non-coding RNAs and UTRs from RNA-seq reads mapped to a
213                                              Non-coding RNAs are fundamental to the competing endogen
214                                         Long non-coding RNAs are important regulators of biological p
215 teracting RNAs (piRNAs) are a class of small non-coding RNAs essential for fertility.
216 n be achieved in three steps: distinguishing non-coding RNAs from protein coding gene transcripts, se
217                                              Non-coding RNAs generated from heterochromatic regions a
218         Circular RNAs (circRNAs), a class of non-coding RNAs generated from non-canonical back-splici
219                                        Small non-coding RNAs have gained substantial attention due to
220     We find that alignments for several long non-coding RNAs previously shown to lack covariation sup
221 ing of EVs identifies diverse RBPs and small non-coding RNAs requiring the LC3-conjugation machinery
222 lasma contains > 40,000 different coding and non-coding RNAs that are potential biomarkers for human
223                   MicroRNAs (miRs) are small non-coding RNAs that can have large impacts on oncogenic
224                 MicroRNAs (miRNAs) are small non-coding RNAs that have been successfully identified t
225                MicroRNAs (miRNAs) are short, non-coding RNAs that modulate the translation-rate of me
226                               Small RNAs are non-coding RNAs that play important roles in the lives o
227                           MicroRNA are small non-coding RNAs that post-transcriptionally regulate the
228                 However, the contribution of non-coding RNAs to complex traits is not clear.
229            Numerous differentially expressed non-coding RNAs were identified and quantified and poten
230                     MicroRNA-27a/b are small non-coding RNAs which are reported to regulate inflammat
231                 miRNAs are a large family of non-coding RNAs which play important roles in translatio
232                             MiRNAs are small non-coding RNAs which post-transcriptionally regulate ge
233  chromosomes are active and express the long non-coding RNAs X active coating transcript (XACT) and X
234 m of m(6)A modifications (in both coding and non-coding RNAs) in cancer pathogenesis and drug respons
235 gth, mature tRNAs and other structured small non-coding RNAs, and less abundant tRNA fragments and ma
236 lysis of changes in genome methylation, long non-coding RNAs, circular RNAs, micro-RNAs and fruit met
237  most eukaryotic pre-messenger RNAs and long non-coding RNAs, introns are removed through the process
238 ch of these genes, either coding proteins or non-coding RNAs, is or are responsible for DFNA58 HL.
239 found not only in messenger RNAs but also in non-coding RNAs, m(6)A affects the fate of the modified
240  processed for EXO-NGS, we observed two long non-coding RNAs, malat-1 and CRNDE to be variably expres
241 ied three highly abundant HHV-6 encoded long non-coding RNAs, one of which generates a non-polyadenyl
242  sequence-divergent but structurally related non-coding RNAs, share RNP networks and that network hub
243 transcription factor binding motifs and long non-coding RNAs, that potentially contribute to organoge
244  modification and chromatin remodelling, and non-coding RNAs, the manipulation of these mechanisms is
245            Enhancer RNAs (eRNA) are unstable non-coding RNAs, transcribed bidirectionally from active
246  element family member, which generates long non-coding RNAs.
247 osine release and expression of certain long non-coding RNAs.
248 hers function broadly across both coding and non-coding RNAs.
249 nuclear RNA degradation, primarily targeting non-coding RNAs.
250 oteins, post-translational modifications and non-coding RNAs.
251 ying localization consistent with other long non-coding RNAs.
252 essing and/or degradation of both coding and non-coding RNAs.
253 ntially targeted by differentially expressed non-coding RNAs.
254 t addition to the ever-expanding pantheon of non-coding RNAs.
255 cations, and regulation of transcription via non-coding RNAs.
256 tified and characterized on mRNA and various non-coding RNAs.
257 to cis-regulatory elements (CREs), which are non-coding segments of DNA that spatially and temporally
258 isted by a Foxp3 enhancer known as conserved non-coding sequence 1 (CNS1)(2-4).
259 ed by genome-wide association studies map to non-coding sequence and their tissue-specific effects in
260  how emerging findings regarding the role of non-coding sequence variation offer opportunities for un
261  be driven in part by variation in conserved non-coding sequences (CNS).
262  Our results shed light on the importance of non-coding sequences in the evolution of the S-locus, an
263     Small non-coding RNAs (ncRNAs) are short non-coding sequences involved in gene regulation in many
264 llion people, with risk variants enriched in non-coding sequences near chondrocyte genes, loci that l
265 thin 3'UTRs that results in species-specific non-coding sequences that may contribute to bacterial di
266  and fails to distinguish between coding and non-coding sequences.
267                     These data indicate that non-coding somatic mutations disrupt the PAX8 transcript
268 the other hand, allows for identification of non-coding somatic variation and expanded estimation of
269    U1 snRNP (U1), vertebrates' most abundant non-coding (spliceosomal) small nuclear RNA, silences pr
270                   Most of these variants are non-coding, suggesting that regulatory effects may drive
271                  We identified clustering of non-coding SVs around neuroactive ligand-receptor intera
272 t cis-sQTL for the alternative splicing of a non-coding transcript of EPB41L4A, called EPB41L4A-203.
273    In addition, the level of Per2AS, a novel non-coding transcript that is expressed at the Period 2
274                                              Non-coding transcriptional regulatory elements are criti
275 pe, Gr and r mutant fruits at the coding and non-coding transcriptomic, metabolomic and genome methyl
276 al surveillance whereby only a subset of the non-coding transcripts is allowed to attain sufficient s
277   In this work, we annotated viral mRNAs and non-coding transcripts, and a large number of transcript
278 notated 27 969 protein-coding genes and 6747 non-coding transcripts.
279                         How mutations in the non-coding U8 snoRNA cause the neurological disorder leu
280 scale population sequencing data in studying non-coding variant classes.
281 g the distribution of the probability that a non-coding variant disrupts regulatory activities.
282 nd functionally validated a novel pathogenic non-coding variant in a small family with a previously u
283 ting eQTLs in the DGRP, including one common non-coding variant that lowers enteric infection suscept
284            Establishing causal links between non-coding variants and human phenotypes is an increasin
285                                     For one, non-coding variants are present at much higher number in
286                The odds ratio for qualifying non-coding variants considered independently from coding
287                                              Non-coding variants have been shown to be related to dis
288  (IRT), to predict the regulatory targets of non-coding variants identified in studies of eQTLs.
289 o the regulatory role of enhancer-associated non-coding variants in cancer epigenome, and to facilita
290 investigation of functional contributions of non-coding variants in cancer epigenome.
291 only, coding alteration only, or coding plus non-coding variants in experimentally predicted regulato
292         Predicting the regulatory effects of non-coding variants on candidate genes is a key step in
293                                              Non-coding variants present a unique challenge for such
294                 We show that 71% of all rare non-coding variants previously proposed as causal lead t
295                                              Non-coding variants remain particularly difficult to int
296            Finally, we identified four novel non-coding variants that cause disease through the disru
297        Previous genome-wide scans found many non-coding variants under selection, suggesting a pressi
298 lements (RE) and genes perturbed by acquired non-coding variants, here we establish epigenomic and tr
299 nally, our study emphasizes the relevance of non-coding variation in genetic studies of complex disea
300 es (DEGs), including both protein-coding and non-coding, were detected in astrocytes, oligodendrocyte

 
Page Top